nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—ABCC2—epilepsy syndrome	0.277	1	CbGaD
Ofloxacin—ABCC2—Levetiracetam—epilepsy syndrome	0.08	0.19	CbGbCtD
Ofloxacin—ABCC1—Phenobarbital—epilepsy syndrome	0.0496	0.118	CbGbCtD
Ofloxacin—ABCC2—Carbamazepine—epilepsy syndrome	0.0459	0.109	CbGbCtD
Ofloxacin—ABCC2—Phenytoin—epilepsy syndrome	0.0412	0.0981	CbGbCtD
Ofloxacin—ABCC2—Phenobarbital—epilepsy syndrome	0.0367	0.0875	CbGbCtD
Ofloxacin—SLC22A5—Valproic Acid—epilepsy syndrome	0.0353	0.084	CbGbCtD
Ofloxacin—SLC22A6—Acetazolamide—epilepsy syndrome	0.0269	0.064	CbGbCtD
Ofloxacin—SLC22A6—Valproic Acid—epilepsy syndrome	0.0201	0.0478	CbGbCtD
Ofloxacin—CYP1A2—Carbamazepine—epilepsy syndrome	0.0171	0.0408	CbGbCtD
Ofloxacin—CYP1A2—Primidone—epilepsy syndrome	0.016	0.0381	CbGbCtD
Ofloxacin—CYP1A2—Propofol—epilepsy syndrome	0.0143	0.0341	CbGbCtD
Ofloxacin—CYP1A2—Phenobarbital—epilepsy syndrome	0.0137	0.0326	CbGbCtD
Ofloxacin—CYP1A2—Diazepam—epilepsy syndrome	0.013	0.0309	CbGbCtD
Ofloxacin—CYP1A2—Valproic Acid—epilepsy syndrome	0.0102	0.0244	CbGbCtD
Ofloxacin—TOP2A—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.00196	0.768	CbGdCrCtD
Ofloxacin—Sparfloxacin—ABCC2—epilepsy syndrome	0.000491	0.304	CrCbGaD
Ofloxacin—Lomefloxacin—ABCC2—epilepsy syndrome	0.000404	0.25	CrCbGaD
Ofloxacin—Gatifloxacin—ALB—epilepsy syndrome	0.00029	0.18	CrCbGaD
Ofloxacin—TOP2A—Bortezomib—Lacosamide—epilepsy syndrome	0.000258	0.101	CbGdCrCtD
Ofloxacin—Sparfloxacin—ABCB1—epilepsy syndrome	0.000181	0.112	CrCbGaD
Ofloxacin—TOP2A—Niclosamide—Clonazepam—epilepsy syndrome	0.000179	0.0703	CbGdCrCtD
Ofloxacin—TOP2A—Chlorpromazine—Clobazam—epilepsy syndrome	0.000153	0.0602	CbGdCrCtD
Ofloxacin—Levofloxacin—ABCB1—epilepsy syndrome	0.000127	0.0787	CrCbGaD
Ofloxacin—Ciprofloxacin—ABCB1—epilepsy syndrome	0.000123	0.076	CrCbGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.64e-05	0.000895	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	3.63e-05	0.000894	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	3.62e-05	0.00089	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	3.59e-05	0.000883	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—APEX1—epilepsy syndrome	3.57e-05	0.000878	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.53e-05	0.000867	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.51e-05	0.000864	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.51e-05	0.000864	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.48e-05	0.000857	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GAMT—epilepsy syndrome	3.47e-05	0.000854	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—EPM2A—epilepsy syndrome	3.47e-05	0.000854	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NHLRC1—epilepsy syndrome	3.47e-05	0.000854	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PNPO—epilepsy syndrome	3.47e-05	0.000854	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PFKL—epilepsy syndrome	3.43e-05	0.000845	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	3.41e-05	0.000838	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.4e-05	0.000837	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.4e-05	0.000837	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.37e-05	0.000829	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.36e-05	0.000827	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.36e-05	0.000827	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.28e-05	0.000808	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.25e-05	0.0008	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	3.24e-05	0.000796	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	3.24e-05	0.000796	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CA4—epilepsy syndrome	3.23e-05	0.000794	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—QDPR—epilepsy syndrome	3.23e-05	0.000794	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.23e-05	0.000793	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—APEX1—epilepsy syndrome	3.19e-05	0.000785	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	3.16e-05	0.000778	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.15e-05	0.000775	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.15e-05	0.000774	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STX1B—epilepsy syndrome	3.14e-05	0.000773	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.13e-05	0.00077	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	3.07e-05	0.000756	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.03e-05	0.000746	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—COX3—epilepsy syndrome	3.03e-05	0.000746	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3e-05	0.000738	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3e-05	0.000738	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—JUN—epilepsy syndrome	2.95e-05	0.000726	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—GBE1—epilepsy syndrome	2.92e-05	0.000718	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PPP1R3C—epilepsy syndrome	2.92e-05	0.000718	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CPSF4—epilepsy syndrome	2.92e-05	0.000718	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.92e-05	0.000717	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	2.88e-05	0.000708	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CACNA2D2—epilepsy syndrome	2.88e-05	0.000707	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PFKL—epilepsy syndrome	2.88e-05	0.000707	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC6A8—epilepsy syndrome	2.88e-05	0.000707	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLCO1A2—epilepsy syndrome	2.88e-05	0.000707	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—KCNB1—epilepsy syndrome	2.88e-05	0.000707	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.87e-05	0.000705	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—H2AFX—epilepsy syndrome	2.85e-05	0.000702	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.84e-05	0.000698	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.81e-05	0.000691	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—epilepsy syndrome	2.8e-05	0.000688	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.79e-05	0.000687	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.79e-05	0.000687	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP2C19—epilepsy syndrome	2.78e-05	0.000684	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.78e-05	0.000683	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP11A1—epilepsy syndrome	2.76e-05	0.00068	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.76e-05	0.000678	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.74e-05	0.000675	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.74e-05	0.000674	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.73e-05	0.00067	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.7e-05	0.000665	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.69e-05	0.00066	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.67e-05	0.000657	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—UPB1—epilepsy syndrome	2.63e-05	0.000647	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NEU1—epilepsy syndrome	2.63e-05	0.000647	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ATIC—epilepsy syndrome	2.63e-05	0.000647	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	2.62e-05	0.000644	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	2.6e-05	0.00064	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—H2AFX—epilepsy syndrome	2.55e-05	0.000627	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HSD17B4—epilepsy syndrome	2.53e-05	0.000623	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	2.52e-05	0.000621	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP2D6—epilepsy syndrome	2.49e-05	0.000613	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.47e-05	0.000607	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.46e-05	0.000605	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	2.45e-05	0.000603	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.45e-05	0.000602	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GBE1—epilepsy syndrome	2.45e-05	0.000601	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPP1R3C—epilepsy syndrome	2.45e-05	0.000601	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ST3GAL3—epilepsy syndrome	2.43e-05	0.000598	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.39e-05	0.000588	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.37e-05	0.000584	CbGpPWpGaD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.37e-05	9.2e-05	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.37e-05	0.000583	CbGpPWpGaD
Ofloxacin—Hypotension—Valproic Acid—epilepsy syndrome	2.37e-05	9.18e-05	CcSEcCtD
Ofloxacin—Asthenia—Carbamazepine—epilepsy syndrome	2.37e-05	9.17e-05	CcSEcCtD
Ofloxacin—Agitation—Gabapentin—epilepsy syndrome	2.36e-05	9.17e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Phenytoin—epilepsy syndrome	2.36e-05	9.17e-05	CcSEcCtD
Ofloxacin—Discomfort—Pregabalin—epilepsy syndrome	2.36e-05	9.15e-05	CcSEcCtD
Ofloxacin—Nausea—Fosphenytoin—epilepsy syndrome	2.36e-05	9.14e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.35e-05	9.12e-05	CcSEcCtD
Ofloxacin—Erythema multiforme—Topiramate—epilepsy syndrome	2.35e-05	9.12e-05	CcSEcCtD
Ofloxacin—Angioedema—Gabapentin—epilepsy syndrome	2.35e-05	9.11e-05	CcSEcCtD
Ofloxacin—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.35e-05	9.11e-05	CcSEcCtD
Ofloxacin—Vomiting—Felbamate—epilepsy syndrome	2.34e-05	9.09e-05	CcSEcCtD
Ofloxacin—Dry mouth—Pregabalin—epilepsy syndrome	2.34e-05	9.06e-05	CcSEcCtD
Ofloxacin—Pruritus—Carbamazepine—epilepsy syndrome	2.33e-05	9.05e-05	CcSEcCtD
Ofloxacin—Rash—Felbamate—epilepsy syndrome	2.32e-05	9.01e-05	CcSEcCtD
Ofloxacin—Eye disorder—Topiramate—epilepsy syndrome	2.32e-05	9.01e-05	CcSEcCtD
Ofloxacin—Dermatitis—Felbamate—epilepsy syndrome	2.32e-05	9.01e-05	CcSEcCtD
Ofloxacin—Malaise—Gabapentin—epilepsy syndrome	2.32e-05	9e-05	CcSEcCtD
Ofloxacin—Tinnitus—Topiramate—epilepsy syndrome	2.32e-05	8.99e-05	CcSEcCtD
Ofloxacin—Vertigo—Gabapentin—epilepsy syndrome	2.31e-05	8.96e-05	CcSEcCtD
Ofloxacin—Headache—Felbamate—epilepsy syndrome	2.31e-05	8.96e-05	CcSEcCtD
Ofloxacin—Confusional state—Pregabalin—epilepsy syndrome	2.31e-05	8.95e-05	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.31e-05	8.95e-05	CcSEcCtD
Ofloxacin—Cardiac disorder—Topiramate—epilepsy syndrome	2.31e-05	8.95e-05	CcSEcCtD
Ofloxacin—Flushing—Topiramate—epilepsy syndrome	2.31e-05	8.95e-05	CcSEcCtD
Ofloxacin—Syncope—Gabapentin—epilepsy syndrome	2.31e-05	8.95e-05	CcSEcCtD
Ofloxacin—Leukopenia—Gabapentin—epilepsy syndrome	2.3e-05	8.93e-05	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.3e-05	0.000566	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.3e-05	0.000566	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.3e-05	0.000566	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ASAH1—epilepsy syndrome	2.3e-05	0.000565	CbGpPWpGaD
Ofloxacin—Dizziness—Clonazepam—epilepsy syndrome	2.3e-05	8.92e-05	CcSEcCtD
Ofloxacin—Nausea—Vigabatrin—epilepsy syndrome	2.3e-05	8.91e-05	CcSEcCtD
Ofloxacin—Vomiting—Zonisamide—epilepsy syndrome	2.29e-05	8.9e-05	CcSEcCtD
Ofloxacin—Insomnia—Valproic Acid—epilepsy syndrome	2.29e-05	8.88e-05	CcSEcCtD
Ofloxacin—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.29e-05	8.88e-05	CcSEcCtD
Ofloxacin—Oedema—Pregabalin—epilepsy syndrome	2.29e-05	8.88e-05	CcSEcCtD
Ofloxacin—Asthenia—Lamotrigine—epilepsy syndrome	2.29e-05	8.87e-05	CcSEcCtD
Ofloxacin—Dizziness—Phenytoin—epilepsy syndrome	2.28e-05	8.86e-05	CcSEcCtD
Ofloxacin—Rash—Zonisamide—epilepsy syndrome	2.27e-05	8.82e-05	CcSEcCtD
Ofloxacin—Infection—Pregabalin—epilepsy syndrome	2.27e-05	8.82e-05	CcSEcCtD
Ofloxacin—Paraesthesia—Valproic Acid—epilepsy syndrome	2.27e-05	8.82e-05	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.27e-05	0.000559	CbGpPWpGaD
Ofloxacin—Palpitations—Gabapentin—epilepsy syndrome	2.27e-05	8.82e-05	CcSEcCtD
Ofloxacin—Dermatitis—Zonisamide—epilepsy syndrome	2.27e-05	8.82e-05	CcSEcCtD
Ofloxacin—Dizziness—Oxcarbazepine—epilepsy syndrome	2.27e-05	8.81e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	2.27e-05	0.000559	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.26e-05	0.000557	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	2.26e-05	0.000557	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	2.26e-05	0.000557	CbGpPWpGaD
Ofloxacin—Nausea—Diazepam—epilepsy syndrome	2.26e-05	8.77e-05	CcSEcCtD
Ofloxacin—Loss of consciousness—Gabapentin—epilepsy syndrome	2.26e-05	8.77e-05	CcSEcCtD
Ofloxacin—Headache—Zonisamide—epilepsy syndrome	2.26e-05	8.77e-05	CcSEcCtD
Ofloxacin—Dyspnoea—Valproic Acid—epilepsy syndrome	2.26e-05	8.76e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Carbamazepine—epilepsy syndrome	2.26e-05	8.75e-05	CcSEcCtD
Ofloxacin—Angiopathy—Topiramate—epilepsy syndrome	2.26e-05	8.75e-05	CcSEcCtD
Ofloxacin—Pruritus—Lamotrigine—epilepsy syndrome	2.25e-05	8.74e-05	CcSEcCtD
Ofloxacin—Shock—Pregabalin—epilepsy syndrome	2.25e-05	8.73e-05	CcSEcCtD
Ofloxacin—Somnolence—Valproic Acid—epilepsy syndrome	2.25e-05	8.73e-05	CcSEcCtD
Ofloxacin—Immune system disorder—Topiramate—epilepsy syndrome	2.25e-05	8.71e-05	CcSEcCtD
Ofloxacin—Nervous system disorder—Pregabalin—epilepsy syndrome	2.24e-05	8.71e-05	CcSEcCtD
Ofloxacin—Cough—Gabapentin—epilepsy syndrome	2.24e-05	8.7e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	2.24e-05	0.000552	CbGpPWpGaD
Ofloxacin—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.24e-05	8.69e-05	CcSEcCtD
Ofloxacin—Mediastinal disorder—Topiramate—epilepsy syndrome	2.24e-05	8.69e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—STXBP1—epilepsy syndrome	2.24e-05	0.00055	CbGpPWpGaD
Ofloxacin—Tachycardia—Pregabalin—epilepsy syndrome	2.23e-05	8.66e-05	CcSEcCtD
Ofloxacin—Chills—Topiramate—epilepsy syndrome	2.23e-05	8.65e-05	CcSEcCtD
Ofloxacin—Dyspepsia—Valproic Acid—epilepsy syndrome	2.23e-05	8.64e-05	CcSEcCtD
Ofloxacin—Skin disorder—Pregabalin—epilepsy syndrome	2.22e-05	8.62e-05	CcSEcCtD
Ofloxacin—Hypertension—Gabapentin—epilepsy syndrome	2.22e-05	8.61e-05	CcSEcCtD
Ofloxacin—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.21e-05	8.58e-05	CcSEcCtD
Ofloxacin—Vomiting—Clonazepam—epilepsy syndrome	2.21e-05	8.57e-05	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	2.2e-05	0.000542	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.2e-05	0.000541	CbGpPWpGaD
Ofloxacin—Decreased appetite—Valproic Acid—epilepsy syndrome	2.2e-05	8.54e-05	CcSEcCtD
Ofloxacin—Alopecia—Topiramate—epilepsy syndrome	2.2e-05	8.52e-05	CcSEcCtD
Ofloxacin—Vomiting—Phenytoin—epilepsy syndrome	2.2e-05	8.52e-05	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.19e-05	0.00054	CbGpPWpGaD
Ofloxacin—Rash—Clonazepam—epilepsy syndrome	2.19e-05	8.5e-05	CcSEcCtD
Ofloxacin—Dermatitis—Clonazepam—epilepsy syndrome	2.19e-05	8.5e-05	CcSEcCtD
Ofloxacin—Myalgia—Gabapentin—epilepsy syndrome	2.19e-05	8.49e-05	CcSEcCtD
Ofloxacin—Chest pain—Gabapentin—epilepsy syndrome	2.19e-05	8.49e-05	CcSEcCtD
Ofloxacin—Arthralgia—Gabapentin—epilepsy syndrome	2.19e-05	8.49e-05	CcSEcCtD
Ofloxacin—Nausea—Felbamate—epilepsy syndrome	2.19e-05	8.49e-05	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.19e-05	8.48e-05	CcSEcCtD
Ofloxacin—Vomiting—Oxcarbazepine—epilepsy syndrome	2.18e-05	8.47e-05	CcSEcCtD
Ofloxacin—Fatigue—Valproic Acid—epilepsy syndrome	2.18e-05	8.47e-05	CcSEcCtD
Ofloxacin—Anxiety—Gabapentin—epilepsy syndrome	2.18e-05	8.46e-05	CcSEcCtD
Ofloxacin—Anorexia—Pregabalin—epilepsy syndrome	2.18e-05	8.46e-05	CcSEcCtD
Ofloxacin—Dizziness—Carbamazepine—epilepsy syndrome	2.18e-05	8.46e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Lamotrigine—epilepsy syndrome	2.18e-05	8.46e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—NT5E—epilepsy syndrome	2.18e-05	0.000536	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALAD—epilepsy syndrome	2.18e-05	0.000536	CbGpPWpGaD
Ofloxacin—Headache—Clonazepam—epilepsy syndrome	2.18e-05	8.45e-05	CcSEcCtD
Ofloxacin—Rash—Phenytoin—epilepsy syndrome	2.18e-05	8.45e-05	CcSEcCtD
Ofloxacin—Mental disorder—Topiramate—epilepsy syndrome	2.18e-05	8.45e-05	CcSEcCtD
Ofloxacin—Dermatitis—Phenytoin—epilepsy syndrome	2.18e-05	8.44e-05	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.17e-05	8.43e-05	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.17e-05	0.000533	CbGpPWpGaD
Ofloxacin—Rash—Oxcarbazepine—epilepsy syndrome	2.17e-05	8.4e-05	CcSEcCtD
Ofloxacin—Pain—Valproic Acid—epilepsy syndrome	2.17e-05	8.4e-05	CcSEcCtD
Ofloxacin—Constipation—Valproic Acid—epilepsy syndrome	2.17e-05	8.4e-05	CcSEcCtD
Ofloxacin—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.16e-05	8.39e-05	CcSEcCtD
Ofloxacin—Headache—Phenytoin—epilepsy syndrome	2.16e-05	8.39e-05	CcSEcCtD
Ofloxacin—Erythema—Topiramate—epilepsy syndrome	2.16e-05	8.39e-05	CcSEcCtD
Ofloxacin—Malnutrition—Topiramate—epilepsy syndrome	2.16e-05	8.39e-05	CcSEcCtD
Ofloxacin—Discomfort—Gabapentin—epilepsy syndrome	2.16e-05	8.39e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	2.16e-05	0.000531	CbGpPWpGaD
Ofloxacin—Headache—Oxcarbazepine—epilepsy syndrome	2.15e-05	8.35e-05	CcSEcCtD
Ofloxacin—Nausea—Zonisamide—epilepsy syndrome	2.14e-05	8.31e-05	CcSEcCtD
Ofloxacin—Dry mouth—Gabapentin—epilepsy syndrome	2.14e-05	8.31e-05	CcSEcCtD
Ofloxacin—Hypotension—Pregabalin—epilepsy syndrome	2.14e-05	8.3e-05	CcSEcCtD
Ofloxacin—Flatulence—Topiramate—epilepsy syndrome	2.13e-05	8.27e-05	CcSEcCtD
Ofloxacin—Tension—Topiramate—epilepsy syndrome	2.12e-05	8.24e-05	CcSEcCtD
Ofloxacin—Dysgeusia—Topiramate—epilepsy syndrome	2.12e-05	8.22e-05	CcSEcCtD
Ofloxacin—Confusional state—Gabapentin—epilepsy syndrome	2.12e-05	8.21e-05	CcSEcCtD
Ofloxacin—Dizziness—Lamotrigine—epilepsy syndrome	2.11e-05	8.17e-05	CcSEcCtD
Ofloxacin—Nervousness—Topiramate—epilepsy syndrome	2.1e-05	8.15e-05	CcSEcCtD
Ofloxacin—Oedema—Gabapentin—epilepsy syndrome	2.1e-05	8.14e-05	CcSEcCtD
Ofloxacin—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.1e-05	8.14e-05	CcSEcCtD
Ofloxacin—Vomiting—Carbamazepine—epilepsy syndrome	2.1e-05	8.13e-05	CcSEcCtD
Ofloxacin—Back pain—Topiramate—epilepsy syndrome	2.09e-05	8.12e-05	CcSEcCtD
Ofloxacin—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.09e-05	8.09e-05	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.09e-05	8.09e-05	CcSEcCtD
Ofloxacin—Infection—Gabapentin—epilepsy syndrome	2.09e-05	8.09e-05	CcSEcCtD
Ofloxacin—Muscle spasms—Topiramate—epilepsy syndrome	2.08e-05	8.07e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CACNA1A—epilepsy syndrome	2.08e-05	0.000511	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALDH7A1—epilepsy syndrome	2.08e-05	0.000511	CbGpPWpGaD
Ofloxacin—Rash—Carbamazepine—epilepsy syndrome	2.08e-05	8.06e-05	CcSEcCtD
Ofloxacin—Dermatitis—Carbamazepine—epilepsy syndrome	2.08e-05	8.06e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—ATM—epilepsy syndrome	2.07e-05	0.00051	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.07e-05	8.03e-05	CcSEcCtD
Ofloxacin—Insomnia—Pregabalin—epilepsy syndrome	2.07e-05	8.03e-05	CcSEcCtD
Ofloxacin—Nausea—Clonazepam—epilepsy syndrome	2.07e-05	8.01e-05	CcSEcCtD
Ofloxacin—Headache—Carbamazepine—epilepsy syndrome	2.07e-05	8.01e-05	CcSEcCtD
Ofloxacin—Shock—Gabapentin—epilepsy syndrome	2.06e-05	8.01e-05	CcSEcCtD
Ofloxacin—Nervous system disorder—Gabapentin—epilepsy syndrome	2.06e-05	7.98e-05	CcSEcCtD
Ofloxacin—Paraesthesia—Pregabalin—epilepsy syndrome	2.06e-05	7.97e-05	CcSEcCtD
Ofloxacin—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.06e-05	7.97e-05	CcSEcCtD
Ofloxacin—Nausea—Phenytoin—epilepsy syndrome	2.05e-05	7.96e-05	CcSEcCtD
Ofloxacin—Tachycardia—Gabapentin—epilepsy syndrome	2.05e-05	7.95e-05	CcSEcCtD
Ofloxacin—Dyspnoea—Pregabalin—epilepsy syndrome	2.04e-05	7.92e-05	CcSEcCtD
Ofloxacin—Nausea—Oxcarbazepine—epilepsy syndrome	2.04e-05	7.92e-05	CcSEcCtD
Ofloxacin—Vision blurred—Topiramate—epilepsy syndrome	2.04e-05	7.91e-05	CcSEcCtD
Ofloxacin—Skin disorder—Gabapentin—epilepsy syndrome	2.04e-05	7.91e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ST3GAL3—epilepsy syndrome	2.04e-05	0.0005	CbGpPWpGaD
Ofloxacin—Somnolence—Pregabalin—epilepsy syndrome	2.03e-05	7.89e-05	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—PRKCB—epilepsy syndrome	2.03e-05	0.000499	CbGpPWpGaD
Ofloxacin—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.03e-05	7.87e-05	CcSEcCtD
Ofloxacin—Tremor—Topiramate—epilepsy syndrome	2.03e-05	7.86e-05	CcSEcCtD
Ofloxacin—Vomiting—Lamotrigine—epilepsy syndrome	2.03e-05	7.86e-05	CcSEcCtD
Ofloxacin—Urticaria—Valproic Acid—epilepsy syndrome	2.01e-05	7.8e-05	CcSEcCtD
Ofloxacin—Rash—Lamotrigine—epilepsy syndrome	2.01e-05	7.79e-05	CcSEcCtD
Ofloxacin—Ill-defined disorder—Topiramate—epilepsy syndrome	2.01e-05	7.79e-05	CcSEcCtD
Ofloxacin—Dermatitis—Lamotrigine—epilepsy syndrome	2.01e-05	7.79e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Valproic Acid—epilepsy syndrome	2e-05	7.76e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Valproic Acid—epilepsy syndrome	2e-05	7.76e-05	CcSEcCtD
Ofloxacin—Anorexia—Gabapentin—epilepsy syndrome	2e-05	7.76e-05	CcSEcCtD
Ofloxacin—Anaemia—Topiramate—epilepsy syndrome	2e-05	7.76e-05	CcSEcCtD
Ofloxacin—Headache—Lamotrigine—epilepsy syndrome	2e-05	7.74e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ADSL—epilepsy syndrome	1.99e-05	0.00049	CbGpPWpGaD
Ofloxacin—Decreased appetite—Pregabalin—epilepsy syndrome	1.99e-05	7.72e-05	CcSEcCtD
Ofloxacin—Agitation—Topiramate—epilepsy syndrome	1.99e-05	7.71e-05	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.98e-05	7.66e-05	CcSEcCtD
Ofloxacin—Fatigue—Pregabalin—epilepsy syndrome	1.97e-05	7.65e-05	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.97e-05	0.000485	CbGpPWpGaD
Ofloxacin—Hypotension—Gabapentin—epilepsy syndrome	1.96e-05	7.61e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	1.96e-05	0.000482	CbGpPWpGaD
Ofloxacin—Nausea—Carbamazepine—epilepsy syndrome	1.96e-05	7.6e-05	CcSEcCtD
Ofloxacin—Constipation—Pregabalin—epilepsy syndrome	1.96e-05	7.59e-05	CcSEcCtD
Ofloxacin—Pain—Pregabalin—epilepsy syndrome	1.96e-05	7.59e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—GLUL—epilepsy syndrome	1.96e-05	0.000481	CbGpPWpGaD
Ofloxacin—Malaise—Topiramate—epilepsy syndrome	1.95e-05	7.57e-05	CcSEcCtD
Ofloxacin—Vertigo—Topiramate—epilepsy syndrome	1.94e-05	7.54e-05	CcSEcCtD
Ofloxacin—Syncope—Topiramate—epilepsy syndrome	1.94e-05	7.53e-05	CcSEcCtD
Ofloxacin—Leukopenia—Topiramate—epilepsy syndrome	1.94e-05	7.51e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CACNA1D—epilepsy syndrome	1.92e-05	0.000472	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.91e-05	7.42e-05	CcSEcCtD
Ofloxacin—Palpitations—Topiramate—epilepsy syndrome	1.91e-05	7.42e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—CA13—epilepsy syndrome	1.9e-05	0.000468	CbGpPWpGaD
Ofloxacin—Loss of consciousness—Topiramate—epilepsy syndrome	1.9e-05	7.38e-05	CcSEcCtD
Ofloxacin—Insomnia—Gabapentin—epilepsy syndrome	1.9e-05	7.36e-05	CcSEcCtD
Ofloxacin—Nausea—Lamotrigine—epilepsy syndrome	1.89e-05	7.34e-05	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	1.89e-05	0.000465	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	1.89e-05	0.000465	CbGpPWpGaD
Ofloxacin—Cough—Topiramate—epilepsy syndrome	1.89e-05	7.32e-05	CcSEcCtD
Ofloxacin—Feeling abnormal—Pregabalin—epilepsy syndrome	1.89e-05	7.32e-05	CcSEcCtD
Ofloxacin—Paraesthesia—Gabapentin—epilepsy syndrome	1.88e-05	7.31e-05	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.87e-05	7.26e-05	CcSEcCtD
Ofloxacin—Dyspnoea—Gabapentin—epilepsy syndrome	1.87e-05	7.26e-05	CcSEcCtD
Ofloxacin—Hypertension—Topiramate—epilepsy syndrome	1.87e-05	7.25e-05	CcSEcCtD
Ofloxacin—Somnolence—Gabapentin—epilepsy syndrome	1.87e-05	7.24e-05	CcSEcCtD
Ofloxacin—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.87e-05	7.24e-05	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.86e-05	0.000458	CbGpPWpGaD
Ofloxacin—Dyspepsia—Gabapentin—epilepsy syndrome	1.85e-05	7.17e-05	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.85e-05	0.000454	CbGpPWpGaD
Ofloxacin—Arthralgia—Topiramate—epilepsy syndrome	1.84e-05	7.14e-05	CcSEcCtD
Ofloxacin—Chest pain—Topiramate—epilepsy syndrome	1.84e-05	7.14e-05	CcSEcCtD
Ofloxacin—Myalgia—Topiramate—epilepsy syndrome	1.84e-05	7.14e-05	CcSEcCtD
Ofloxacin—Anxiety—Topiramate—epilepsy syndrome	1.84e-05	7.12e-05	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.83e-05	7.1e-05	CcSEcCtD
Ofloxacin—Decreased appetite—Gabapentin—epilepsy syndrome	1.82e-05	7.08e-05	CcSEcCtD
Ofloxacin—Discomfort—Topiramate—epilepsy syndrome	1.82e-05	7.06e-05	CcSEcCtD
Ofloxacin—Urticaria—Pregabalin—epilepsy syndrome	1.82e-05	7.05e-05	CcSEcCtD
Ofloxacin—Asthenia—Valproic Acid—epilepsy syndrome	1.82e-05	7.05e-05	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.81e-05	7.03e-05	CcSEcCtD
Ofloxacin—Fatigue—Gabapentin—epilepsy syndrome	1.81e-05	7.02e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Pregabalin—epilepsy syndrome	1.81e-05	7.02e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Pregabalin—epilepsy syndrome	1.81e-05	7.02e-05	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.8e-05	0.000444	CbGpPWpGaD
Ofloxacin—Dry mouth—Topiramate—epilepsy syndrome	1.8e-05	6.99e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—TXNRD1—epilepsy syndrome	1.8e-05	0.000441	CbGpPWpGaD
Ofloxacin—Constipation—Gabapentin—epilepsy syndrome	1.79e-05	6.96e-05	CcSEcCtD
Ofloxacin—Pain—Gabapentin—epilepsy syndrome	1.79e-05	6.96e-05	CcSEcCtD
Ofloxacin—Pruritus—Valproic Acid—epilepsy syndrome	1.79e-05	6.95e-05	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.79e-05	0.00044	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.79e-05	0.00044	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.78e-05	0.000439	CbGpPWpGaD
Ofloxacin—Confusional state—Topiramate—epilepsy syndrome	1.78e-05	6.91e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—EIF2AK2—epilepsy syndrome	1.77e-05	0.000435	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.77e-05	0.000435	CbGpPWpGaD
Ofloxacin—Oedema—Topiramate—epilepsy syndrome	1.77e-05	6.85e-05	CcSEcCtD
Ofloxacin—Infection—Topiramate—epilepsy syndrome	1.75e-05	6.8e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—AQP1—epilepsy syndrome	1.74e-05	0.000429	CbGpPWpGaD
Ofloxacin—Shock—Topiramate—epilepsy syndrome	1.74e-05	6.74e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Valproic Acid—epilepsy syndrome	1.73e-05	6.72e-05	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.73e-05	0.000426	CbGpPWpGaD
Ofloxacin—Nervous system disorder—Topiramate—epilepsy syndrome	1.73e-05	6.72e-05	CcSEcCtD
Ofloxacin—Feeling abnormal—Gabapentin—epilepsy syndrome	1.73e-05	6.71e-05	CcSEcCtD
Ofloxacin—Thrombocytopenia—Topiramate—epilepsy syndrome	1.73e-05	6.71e-05	CcSEcCtD
Ofloxacin—Tachycardia—Topiramate—epilepsy syndrome	1.72e-05	6.68e-05	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.72e-05	6.66e-05	CcSEcCtD
Ofloxacin—Skin disorder—Topiramate—epilepsy syndrome	1.72e-05	6.65e-05	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.71e-05	0.000421	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.71e-05	0.000421	CbGpPWpGaD
Ofloxacin—Hyperhidrosis—Topiramate—epilepsy syndrome	1.71e-05	6.62e-05	CcSEcCtD
Ofloxacin—Hypersensitivity—Pregabalin—epilepsy syndrome	1.69e-05	6.54e-05	CcSEcCtD
Ofloxacin—Anorexia—Topiramate—epilepsy syndrome	1.68e-05	6.53e-05	CcSEcCtD
Ofloxacin—Dizziness—Valproic Acid—epilepsy syndrome	1.67e-05	6.49e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.67e-05	0.000412	CbGpPWpGaD
Ofloxacin—Urticaria—Gabapentin—epilepsy syndrome	1.67e-05	6.47e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Gabapentin—epilepsy syndrome	1.66e-05	6.44e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Gabapentin—epilepsy syndrome	1.66e-05	6.44e-05	CcSEcCtD
Ofloxacin—Hypotension—Topiramate—epilepsy syndrome	1.65e-05	6.4e-05	CcSEcCtD
Ofloxacin—Asthenia—Pregabalin—epilepsy syndrome	1.64e-05	6.37e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—PPIA—epilepsy syndrome	1.64e-05	0.000403	CbGpPWpGaD
Ofloxacin—Pruritus—Pregabalin—epilepsy syndrome	1.62e-05	6.28e-05	CcSEcCtD
Ofloxacin—Vomiting—Valproic Acid—epilepsy syndrome	1.61e-05	6.24e-05	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.61e-05	6.24e-05	CcSEcCtD
Ofloxacin—Insomnia—Topiramate—epilepsy syndrome	1.6e-05	6.19e-05	CcSEcCtD
Ofloxacin—Rash—Valproic Acid—epilepsy syndrome	1.6e-05	6.19e-05	CcSEcCtD
Ofloxacin—Dermatitis—Valproic Acid—epilepsy syndrome	1.59e-05	6.19e-05	CcSEcCtD
Ofloxacin—Headache—Valproic Acid—epilepsy syndrome	1.59e-05	6.15e-05	CcSEcCtD
Ofloxacin—Paraesthesia—Topiramate—epilepsy syndrome	1.59e-05	6.15e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—KCNJ11—epilepsy syndrome	1.58e-05	0.000388	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CHRM3—epilepsy syndrome	1.58e-05	0.000388	CbGpPWpGaD
Ofloxacin—Dyspnoea—Topiramate—epilepsy syndrome	1.57e-05	6.11e-05	CcSEcCtD
Ofloxacin—Somnolence—Topiramate—epilepsy syndrome	1.57e-05	6.09e-05	CcSEcCtD
Ofloxacin—Diarrhoea—Pregabalin—epilepsy syndrome	1.57e-05	6.07e-05	CcSEcCtD
Ofloxacin—Dyspepsia—Topiramate—epilepsy syndrome	1.55e-05	6.03e-05	CcSEcCtD
Ofloxacin—Hypersensitivity—Gabapentin—epilepsy syndrome	1.55e-05	6e-05	CcSEcCtD
Ofloxacin—Decreased appetite—Topiramate—epilepsy syndrome	1.54e-05	5.95e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	1.53e-05	0.000376	CbGpPWpGaD
Ofloxacin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.52e-05	5.91e-05	CcSEcCtD
Ofloxacin—Fatigue—Topiramate—epilepsy syndrome	1.52e-05	5.91e-05	CcSEcCtD
Ofloxacin—Dizziness—Pregabalin—epilepsy syndrome	1.51e-05	5.87e-05	CcSEcCtD
Ofloxacin—Pain—Topiramate—epilepsy syndrome	1.51e-05	5.86e-05	CcSEcCtD
Ofloxacin—Constipation—Topiramate—epilepsy syndrome	1.51e-05	5.86e-05	CcSEcCtD
Ofloxacin—Asthenia—Gabapentin—epilepsy syndrome	1.51e-05	5.84e-05	CcSEcCtD
Ofloxacin—Nausea—Valproic Acid—epilepsy syndrome	1.5e-05	5.83e-05	CcSEcCtD
Ofloxacin—Pruritus—Gabapentin—epilepsy syndrome	1.48e-05	5.76e-05	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.48e-05	0.000364	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.47e-05	0.000361	CbGpPWpGaD
Ofloxacin—Vomiting—Pregabalin—epilepsy syndrome	1.46e-05	5.64e-05	CcSEcCtD
Ofloxacin—Feeling abnormal—Topiramate—epilepsy syndrome	1.46e-05	5.64e-05	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.44e-05	5.6e-05	CcSEcCtD
Ofloxacin—Rash—Pregabalin—epilepsy syndrome	1.44e-05	5.6e-05	CcSEcCtD
Ofloxacin—Dermatitis—Pregabalin—epilepsy syndrome	1.44e-05	5.59e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.44e-05	0.000354	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.44e-05	0.000354	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.44e-05	0.000354	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.44e-05	0.000354	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.44e-05	0.000354	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.44e-05	0.000354	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.44e-05	0.000354	CbGpPWpGaD
Ofloxacin—Diarrhoea—Gabapentin—epilepsy syndrome	1.44e-05	5.57e-05	CcSEcCtD
Ofloxacin—Headache—Pregabalin—epilepsy syndrome	1.43e-05	5.56e-05	CcSEcCtD
Ofloxacin—Urticaria—Topiramate—epilepsy syndrome	1.4e-05	5.44e-05	CcSEcCtD
Ofloxacin—Body temperature increased—Topiramate—epilepsy syndrome	1.4e-05	5.41e-05	CcSEcCtD
Ofloxacin—Abdominal pain—Topiramate—epilepsy syndrome	1.4e-05	5.41e-05	CcSEcCtD
Ofloxacin—Dizziness—Gabapentin—epilepsy syndrome	1.39e-05	5.38e-05	CcSEcCtD
Ofloxacin—Nausea—Pregabalin—epilepsy syndrome	1.36e-05	5.27e-05	CcSEcCtD
Ofloxacin—Vomiting—Gabapentin—epilepsy syndrome	1.33e-05	5.18e-05	CcSEcCtD
Ofloxacin—Rash—Gabapentin—epilepsy syndrome	1.32e-05	5.13e-05	CcSEcCtD
Ofloxacin—Dermatitis—Gabapentin—epilepsy syndrome	1.32e-05	5.13e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.32e-05	0.000324	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.32e-05	0.000324	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.32e-05	0.000324	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.32e-05	0.000324	CbGpPWpGaD
Ofloxacin—Headache—Gabapentin—epilepsy syndrome	1.31e-05	5.1e-05	CcSEcCtD
Ofloxacin—Hypersensitivity—Topiramate—epilepsy syndrome	1.3e-05	5.05e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—ABCG2—epilepsy syndrome	1.28e-05	0.000316	CbGpPWpGaD
Ofloxacin—Asthenia—Topiramate—epilepsy syndrome	1.27e-05	4.91e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CYP2C19—epilepsy syndrome	1.25e-05	0.000308	CbGpPWpGaD
Ofloxacin—Pruritus—Topiramate—epilepsy syndrome	1.25e-05	4.85e-05	CcSEcCtD
Ofloxacin—Nausea—Gabapentin—epilepsy syndrome	1.25e-05	4.84e-05	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CYP11A1—epilepsy syndrome	1.24e-05	0.000306	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.24e-05	0.000304	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.23e-05	0.000301	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.23e-05	0.000301	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.22e-05	0.0003	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC2A1—epilepsy syndrome	1.21e-05	0.000298	CbGpPWpGaD
Ofloxacin—Diarrhoea—Topiramate—epilepsy syndrome	1.21e-05	4.69e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—JUNB—epilepsy syndrome	1.2e-05	0.000296	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS1—epilepsy syndrome	1.2e-05	0.000294	CbGpPWpGaD
Ofloxacin—Dizziness—Topiramate—epilepsy syndrome	1.17e-05	4.53e-05	CcSEcCtD
Ofloxacin—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.15e-05	0.000283	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HBEGF—epilepsy syndrome	1.14e-05	0.00028	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.13e-05	0.000277	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP2D6—epilepsy syndrome	1.12e-05	0.000276	CbGpPWpGaD
Ofloxacin—Vomiting—Topiramate—epilepsy syndrome	1.12e-05	4.35e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—AKT3—epilepsy syndrome	1.12e-05	0.000275	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.12e-05	0.000275	CbGpPWpGaD
Ofloxacin—Rash—Topiramate—epilepsy syndrome	1.11e-05	4.32e-05	CcSEcCtD
Ofloxacin—Dermatitis—Topiramate—epilepsy syndrome	1.11e-05	4.31e-05	CcSEcCtD
Ofloxacin—Headache—Topiramate—epilepsy syndrome	1.11e-05	4.29e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—ADAM10—epilepsy syndrome	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.09e-05	0.000269	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.08e-05	0.000266	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.07e-05	0.000263	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ADRA2A—epilepsy syndrome	1.07e-05	0.000263	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.07e-05	0.000263	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—BCHE—epilepsy syndrome	1.06e-05	0.000262	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.06e-05	0.000261	CbGpPWpGaD
Ofloxacin—Nausea—Topiramate—epilepsy syndrome	1.05e-05	4.07e-05	CcSEcCtD
Ofloxacin—ABCC1—Disease—CDC42—epilepsy syndrome	1.02e-05	0.000251	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC2A1—epilepsy syndrome	1.02e-05	0.00025	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PLCB1—epilepsy syndrome	1e-05	0.000247	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TH—epilepsy syndrome	1e-05	0.000246	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NEU1—epilepsy syndrome	9.99e-06	0.000246	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ATIC—epilepsy syndrome	9.99e-06	0.000246	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—UPB1—epilepsy syndrome	9.99e-06	0.000246	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.85e-06	0.000242	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	9.62e-06	0.000237	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HES1—epilepsy syndrome	9.35e-06	0.00023	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GBE1—epilepsy syndrome	9.29e-06	0.000228	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	9.29e-06	0.000228	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FYN—epilepsy syndrome	9.09e-06	0.000224	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.08e-06	0.000223	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—H2AFX—epilepsy syndrome	9.06e-06	0.000223	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—YWHAZ—epilepsy syndrome	8.74e-06	0.000215	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	8.73e-06	0.000215	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	8.5e-06	0.000209	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CCR5—epilepsy syndrome	8.41e-06	0.000207	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—HMOX1—epilepsy syndrome	8.35e-06	0.000205	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NT5E—epilepsy syndrome	8.28e-06	0.000204	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALAD—epilepsy syndrome	8.28e-06	0.000204	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CAT—epilepsy syndrome	8.24e-06	0.000203	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCB1—epilepsy syndrome	8.02e-06	0.000197	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	7.9e-06	0.000194	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	7.9e-06	0.000194	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TSC2—epilepsy syndrome	7.81e-06	0.000192	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	7.73e-06	0.00019	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOE—epilepsy syndrome	7.65e-06	0.000188	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ADSL—epilepsy syndrome	7.57e-06	0.000186	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GPX1—epilepsy syndrome	7.45e-06	0.000183	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GLUL—epilepsy syndrome	7.43e-06	0.000183	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	7.29e-06	0.000179	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6ST—epilepsy syndrome	7.18e-06	0.000177	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS2—epilepsy syndrome	7.13e-06	0.000175	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	6.82e-06	0.000168	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AQP1—epilepsy syndrome	6.62e-06	0.000163	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AGT—epilepsy syndrome	6.54e-06	0.000161	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOE—epilepsy syndrome	6.4e-06	0.000157	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.36e-06	0.000156	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	5.99e-06	0.000147	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	5.99e-06	0.000147	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FGF2—epilepsy syndrome	5.81e-06	0.000143	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.57e-06	0.000137	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—POMC—epilepsy syndrome	5.5e-06	0.000135	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.46e-06	0.000134	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTOR—epilepsy syndrome	5.29e-06	0.00013	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—epilepsy syndrome	5.24e-06	0.000129	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALB—epilepsy syndrome	5.02e-06	0.000123	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	4.88e-06	0.00012	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	4.76e-06	0.000117	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	4.73e-06	0.000116	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.69e-06	0.000115	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—epilepsy syndrome	4.39e-06	0.000108	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.28e-06	0.000105	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	4.26e-06	0.000105	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SRC—epilepsy syndrome	4.24e-06	0.000104	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	4.06e-06	9.98e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—BCHE—epilepsy syndrome	4.04e-06	9.94e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	3.86e-06	9.49e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	3.82e-06	9.38e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TH—epilepsy syndrome	3.8e-06	9.35e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.74e-06	9.2e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.17e-06	7.8e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.13e-06	7.7e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.05e-06	7.49e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.83e-06	6.96e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—epilepsy syndrome	2.63e-06	6.48e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.48e-06	6.1e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.43e-06	5.98e-05	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—epilepsy syndrome	2.21e-06	5.42e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.09e-06	5.14e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.9e-06	4.68e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.67e-06	4.1e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—epilepsy syndrome	8.38e-07	2.06e-05	CbGpPWpGaD
